AXDX
Price:
$1.64
Market Cap:
$41.07M
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk....[Read more]
Industry
Medical - Devices
IPO Date
1994-04-07
Stock Exchange
NASDAQ
Ticker
AXDX
According to Accelerate Diagnostics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 79.39M. This represents a change of 18.13% compared to the average of 67.20M of the last 4 quarters.
The mean historical Enterprise Value of Accelerate Diagnostics, Inc. over the last ten years is 684.70M. The current 79.39M Enterprise Value has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), AXDX's Enterprise Value was at its highest in in the December 2017 quarter at 1.43B. The Enterprise Value was at its lowest in in the March 2024 quarter at 42.90M.
Average
684.70M
Median
732.14M
Minimum
75.99M
Maximum
1.39B
Discovering the peaks and valleys of Accelerate Diagnostics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 82.84%
Maximum Annual Enterprise Value = 1.39B
Minimum Annual Increase = -74.34%
Minimum Annual Enterprise Value = 75.99M
Year | Enterprise Value | Change |
---|---|---|
2023 | 75.99M | -24.74% |
2022 | 100.97M | -74.34% |
2021 | 393.43M | -26.97% |
2020 | 538.76M | -45.81% |
2019 | 994.21M | 46.10% |
2018 | 680.50M | -50.98% |
2017 | 1.39B | 32.88% |
2016 | 1.04B | 23.43% |
2015 | 846.44M | 7.99% |
2014 | 783.78M | 82.84% |
The current Enterprise Value of Accelerate Diagnostics, Inc. (AXDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
190.13M
5-year avg
420.67M
10-year avg
684.70M
Accelerate Diagnostics, Inc.’s Enterprise Value is less than CVRx, Inc. (310.32M), less than NeuroPace, Inc. (347.61M), less than Anika Therapeutics, Inc. (213.70M), less than AxoGen, Inc. (637.27M), less than Artivion, Inc. (1.49B), less than Sight Sciences, Inc. (120.25M), less than Orthofix Medical Inc. (829.81M), less than Avanos Medical, Inc. (968.00M), less than CONMED Corporation (3.22B), less than OrthoPediatrics Corp. (611.40M), less than Surmodics, Inc. (554.56M), less than Integer Holdings Corporation (5.77B), greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (3.12B), less than Electromed, Inc. (238.10M), less than Pulmonx Corporation (260.62M), less than IRadimed Corporation (623.15M),
Company | Enterprise Value | Market cap |
---|---|---|
310.32M | $360.32M | |
347.61M | $289.53M | |
213.70M | $248.54M | |
637.27M | $587.07M | |
1.49B | $1.19B | |
120.25M | $203.53M | |
829.81M | $722.63M | |
968.00M | $854.80M | |
3.22B | $2.31B | |
611.40M | $637.85M | |
554.56M | $561.12M | |
5.77B | $4.63B | |
40.81M | $8.18M | |
3.12B | $2.79B | |
238.10M | $251.96M | |
260.62M | $268.12M | |
623.15M | $674.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accelerate Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accelerate Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Accelerate Diagnostics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Accelerate Diagnostics, Inc. (AXDX)?
What is the 3-year average Enterprise Value for Accelerate Diagnostics, Inc. (AXDX)?
What is the 5-year average Enterprise Value for Accelerate Diagnostics, Inc. (AXDX)?
How does the current Enterprise Value for Accelerate Diagnostics, Inc. (AXDX) compare to its historical average?